In this week’s edition of InnovationRx, we look at health insurers' vows to improve prior authorization, Bell Labs’ IP ...

A new stem cell-based treatment helped most trial participants with severe type 1 diabetes stop insulin use, offering hope ...

Sales of the ground-breaking cystic fibrosis (CF) drug Kaftrio was the main driver behind revenues of a Dublin unit of Vertex ...

CRSP edges ahead of NTLA with the only approved CRISPR therapy, stronger pipeline breadth and recent stock gains.

TIME solicited nominations across sectors including health care, entertainment, fashion, technology, as well as from industry ...

Vertex Pharmaceuticals has received a “Moderate Buy” consensus from 29 brokerages, with most analysts either holding or ...

Patients with occipital headache experienced relief with 60 days of peripheral nerve stimulation, according to data presented ...

In the first quarter, the Victory Diversified Stock Fund A-Shares (without sales charge) underperformed its S&P 500®Index ...

The Victory Munder Multi-Cap Fund A-Shares (without sales charge) underperformed its Russell 3000®Index benchmark by 51 basis ...

Google (NASDAQ:GOOGL) has launched Gemini CLI, a free and open-source AI agent that integrates directly into developers’ ...

The 2025 TIME100 Most Influential Companies issue features two worldwide covers, each spotlighting top executives from a ...